Claudia Dallinger
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Inhalation and Respiratory Drug Delivery
- Pharmaceutical Science top 10%
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Lung Cancer Treatments and Mutations 5
- Renal cell carcinoma treatment 1
-
- MRI in cancer diagnosis 1
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- R. Kaiser (2 shared papers)Rozsa Schlenker‐Herceg (2 shared papers)Kristell Marzin (4 shared papers)Rudolf Binder (1 shared paper)Gerald J. Roth (1 shared paper)Florian Colbatzky (1 shared paper)Frank Hilberg (1 shared paper)Ulrike Schmid (5 shared papers)
- Journals
- The Journal of Clinical Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)Investigational New Drugs (1 paper)Journal of Medicinal Chemistry (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Claudia Dallinger
10 papers receiving 591 citations
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 292
- Pharmaceutical Science 29
- Oncology 94
- Pathology and Forensic Medicine 59
- Organic Chemistry 96
Countries citing papers authored by Claudia Dallinger
This map shows the geographic impact of Claudia Dallinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Dallinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Dallinger more than expected).
Fields of papers citing papers by Claudia Dallinger
This network shows the impact of papers produced by Claudia Dallinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Dallinger. The network helps show where Claudia Dallinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudia Dallinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 264 | |
| 2 | 2019 | 146 | |
| 3 | 2013 | 48 | |
| 4 | 2016 | 47 | |
| 5 | 2018 | 29 | |
| 6 | 2017 | 22 | |
| 7 | 2017 | 22 | |
| 8 | 2017 | 17 | |
| 9 | 2016 | 2 | |
| 10 | 2012 | 1 |
About Claudia Dallinger
Claudia Dallinger is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Organic Chemistry and Oncology, having authored 10 papers that have together received 598 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Lung Cancer Treatments and Mutations (5 papers), Chronic Myeloid Leukemia Treatments (1 paper), HIV/AIDS drug development and treatment (1 paper), Renal cell carcinoma treatment (1 paper), MRI in cancer diagnosis (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (292 citations), Pharmaceutical Science (29 citations), Oncology (94 citations), Pathology and Forensic Medicine (59 citations) and Organic Chemistry (96 citations). Claudia Dallinger has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include R. Kaiser, Rozsa Schlenker‐Herceg, Kristell Marzin, Rudolf Binder, Gerald J. Roth, Florian Colbatzky, Frank Hilberg, Ulrike Schmid, Matthias Freiwald and Peter Stopfer. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Investigational New Drugs, Journal of Medicinal Chemistry and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.